- Home
- CRNT vs ATAI Comparison
CRNT vs ATAI Comparison
Compare CRNT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- ATAI
- Stock Information
- Founded
- CRNT 1996
- ATAI 2018
- Country
- CRNT Israel
- ATAI Germany
- Employees
- CRNT N/A
- ATAI N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- ATAI Health Care
- Exchange
- CRNT Nasdaq
- ATAI Nasdaq
- Market Cap
- CRNT 303.2M
- ATAI 280.2M
- IPO Year
- CRNT 2000
- ATAI 2021
- Fundamental
- Price
- CRNT $3.01
- ATAI $1.99
- Analyst Decision
- CRNT Strong Buy
- ATAI Strong Buy
- Analyst Count
- CRNT 4
- ATAI 4
- Target Price
- CRNT $6.44
- ATAI $9.00
- AVG Volume (30 Days)
- CRNT 2.7M
- ATAI 4.9M
- Earning Date
- CRNT 02-11-2025
- ATAI 03-27-2025
- Dividend Yield
- CRNT N/A
- ATAI N/A
- EPS Growth
- CRNT 285.71
- ATAI N/A
- EPS
- CRNT 0.27
- ATAI N/A
- Revenue
- CRNT $394,190,000.00
- ATAI $331,000.00
- Revenue This Year
- CRNT $5.00
- ATAI $80.07
- Revenue Next Year
- CRNT $5.72
- ATAI N/A
- P/E Ratio
- CRNT $11.15
- ATAI N/A
- Revenue Growth
- CRNT 13.54
- ATAI N/A
- 52 Week Low
- CRNT $2.33
- ATAI $1.03
- 52 Week High
- CRNT $5.73
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- CRNT 28.73
- ATAI 51.96
- Support Level
- CRNT $3.43
- ATAI $1.94
- Resistance Level
- CRNT $3.54
- ATAI $2.16
- Average True Range (ATR)
- CRNT 0.31
- ATAI 0.34
- MACD
- CRNT -0.17
- ATAI -0.03
- Stochastic Oscillator
- CRNT 0.40
- ATAI 48.38
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.